1Department of Regulatory Affairs, Dattakala College of Pharmacy Swami-Chincholi, Pune
*Corresponding author. E-mail address: pravinsalunkhe065@gmail.com (P. Salunkhe)
The Electronic Common Technical Document (eCTD) has become a cornerstone in modern pharmaceutical regulatory submissions, offering a standardized, modular, and digital framework for dossier preparation and review. By integrating structured modules, XML backbone files, hyperlinks, and lifecycle management features, eCTD enhances efficiency, traceability, and compliance across multiple regulatory authorities. This review provides a comprehensive overview of eCTD, detailing its structure, submission process, regional variations, and recent regulatory updates, including the adoption of eCTD v4.0. The manuscript also examines practical insights from industry case studies, highlighting successful global submissions and lessons learned for post-approval lifecycle management. Challenges associated with eCTD implementation, such as technical complexities, regional disparities, data integrity concerns, and operational constraints, are critically discussed. Emerging trends, including artificial intelligence, automation, cloud-based platforms, and blockchain technology, are explored for their potential to improve submission accuracy, reduce review timelines, and enhance regulatory predictability. The review emphasizes the strategic role of eCTD not only as a compliance tool but also as a driver of efficiency, global harmonization, and informed decision-making in regulatory affairs. Understanding these aspects is essential for regulatory professionals, enabling optimized submission workflows and improved management of the pharmaceutical product lifecycle. Overall, eCTD has evolved from a regulatory submission format into a strategic enabler of efficiency, transparency, and global harmonization. Continued adoption of advanced digital technologies will further strengthen lifecycle management and regulatory decision-making.
Overall, eCTD has evolved from a regulatory submission format into a strategic enabler of efficiency, transparency, and global harmonization. Continued adoption of advanced digital technologies will further strengthen lifecycle management and regulatory decision-making.
Electronic Common Technical Document, Regulatory Submission, Pharmaceutical Compliance, ECTD v4.0, Digital Regulatory Affairs